Speaking of Mol Bio10 Helmi 2023

Multi-omics | The importance of science in data science

In this episode, we talk with Chris Whelan about the data behind science. Chris is the Director of Neuroscience, Data Science & Digital Health for Research and Development at The Janssen Pharmaceutical Companies of Johnson & Johnson, as well as the Chair of the UK Biobank Pharma Proteomics project. He connects the dots between genomics and proteomics and clarifies how omics can be used to understand disease biology to inform drug development to treat disease. The conversation touches on the challenges of defining and collecting a comprehensive biomarker panel, and he also delves into the role of data science and the importance of having people that understand biology being involved in data science applications that affect human health.

If you enjoy this great conversation with a leader in his field we hope you’ll subscribe to the series to get future episodes as they drop.

Visit https://thermofisher.com/molbioschool to access molecular biology resources and educational content.

Experience the Speaking of Mol Bio podcast in its extended video format for a more immersive journey, while also ensuring accessibility with downloadable transcripts for each episode.

Watch now at thermofisher.com/podcast-video

Subscribe to get future episodes as they drop and if you like what you’re hearing we hope you’ll share a review or recommend the series to a colleague. 

Visit the Invitrogen School of Molecular Biology to access helpful molecular biology resources and educational content, and please share this resource with anyone you know working in molecular biology.

For Research Use Only. Not for use in diagnostic procedures.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(54)

The tools, stories, and science behind Absolute Gene-ius

Molecular biology is more than a set of techniques. It is a toolkit for asking better questions. In this special crossover episode of Speaking of Mol Bio, Steve Lewis welcomes Jordan Ruggieri, Senior ...

8 Heinä 26min

CRISPR, MPRA, and the genetics of mental health

Some genetic variants may help explain why different psychiatric disorders share overlapping biology. In this episode of Speaking of Mol Bio, host Steve Lewis speaks with Jess McAfee, PhD, and Alejand...

24 Kesä 30min

From prototype to production – solving the scale-up gap

Great science doesn’t always translate into a scalable product, and that gap can stall even the most promising innovations. In this Mol Bio Minutes episode, Steve Lewis explores a common challenge in ...

10 Kesä 7min

The real cost of PCR - beyond price per reaction

Not all experiments are created equal, and neither are the decisions behind them. In this episode, Cam Cyr explores how scientists navigate the balance between cost and performance in molecular biolog...

27 Touko 30min

The molecular toolkit behind HIV research

HIV research is one of the clearest examples of molecular biology in action. In this Mol Bio Minutes episode, Dr. Ryan Jeep walks through how fundamental molecular techniques power everything from det...

13 Touko 14min

DNA-encoded library use in living cells for drug discovery

In this episode of Speaking of Mol Bio, host Steve Lewis speaks with Dr. Leif Larsen, Director of Biology at Vipergen, about the power of DNA-encoded libraries (DELs) in modern drug discovery. DEL tec...

22 Huhti 30min

Choosing the right PCR method for your experiment

In this Mol Bio Minutes mini-episode of Speaking of Mol Bio, Dr. Andrea Hunger walks listeners through the practical differences between three core PCR approaches: endpoint PCR, quantitative PCR (qPCR...

8 Huhti 13min

From bench to bushland ─ developing a koala chlamydia vaccine

In this Season 4 premiere of Speaking of Mol Bio, host Steve Lewis speaks with Dr. Nina Pollak from the University of the Sunshine Coast about the development of a single-dose vaccine aimed at protect...

25 Maalis 36min